Latest Breaking News On - முதல் ஆசிரிய - Page 1 : comparemela.com

Държавата на „Слънцето

Държавата на „Слънцето
frognews.bg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from frognews.bg Daily Mail and Mail on Sunday newspapers.

Sofiya gradBruxelles capitaleBoyko rashkovBoyko borisovBorisovi coFirst facultyFrench kingState himSofia westFor exampleWas notBoykovo systemசோஃபியா கிரத்ப்ரூக்ஸெல்ஸ் தலைநகரம்முதல் ஆசிரியபிரஞ்சு கிங்

PragueMED to Support New Medical Students in the Czech Republic

PragueMED to Support New Medical Students in the Czech Republic
praguemorning.cz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from praguemorning.cz Daily Mail and Mail on Sunday newspapers.

Czech republicUnited kingdomZain awanPraguemed ltdCharles universityFirst facultyசெக் குடியரசுஒன்றுபட்டது கிஂக்டம்ஸேந் அவன்சார்லஸ் பல்கலைக்கழகம்முதல் ஆசிரிய

Telix Pharmaceuticals Limited: Czech Republic First European Country to Grant National Authorisation for the Use of Telix s Prostate Cancer Imaging Product

MELBOURNE, Australia and LIÈGE, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, 'Telix', the 'Company') announces today that the Ministry of Health of the Czech Republic

United statesNew zealandCzech republicStewart holmstromDavid zogalaChristian behrenbruchTelix pharmaceuticalsCzech ministry of healthNuclear medicine instituteUniversity hospital pragueCzech society of nuclear medicineTreatment programmeEuropean unionCorporate communicationsTelix pharmaceuticals limitedMinistry of health the czech republic

Czech Republic First European Country to Grant National Authorisation for the Use of Telix s Prostate Cancer Imaging Product

> Nachricht Czech Republic First European Country to Grant National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product Nachrichtenquelle: globenewswire | 16.02.2021, 07:05 | 163 | 0 MELBOURNE, Australia and LIÈGE, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces today that the Ministry of Health of the Czech Republic is the first European health authority to grant a national authorisation allowing the use of TLX591-CDx (Kit for the preparation of 68Ga-PSMA-11), a radiopharmaceutical targeting Prostate-Specific Membrane Antigen (PSMA) for the imaging of prostate cancer using Positron Emission Tomography (PET). The national authorisation, which is specific to Telix’s prostate cancer imaging product, enables Czech physicians to use

United statesNew zealandCzech republicStewart holmstromDavid zogalaChristian behrenbruchAbouttelix pharmaceuticalsTelix pharmaceuticalsCzech ministry of healthNuclear medicine instituteUniversity hospital pragueAustralian securities exchangeCzech society of nuclear medicineTreatment programmeEuropean unionCorporate communications

Czech Republic First European Country to Grant National Authorisation for the Use of Telix s Prostate Cancer Imaging Product Australian Stock Exchange:TLX AX

Czech Republic First European Country to Grant National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product February 16, 2021 01:05 ET | Source: Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited North Melbourne, AUSTRALIA MELBOURNE, Australia and LIÈGE, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces today that the Ministry of Health of the Czech Republic is the first European health authority to grant a national authorisation allowing the use of TLX591-CDx (Kit for the preparation of 68Ga-PSMA-11), a radiopharmaceutical targeting Prostate-Specific Membrane Antigen (PSMA) for the imaging of prostate cancer using Positron Emission Tomography (PET).

United statesNew zealandCzech republicStewart holmstromDavid zogalaChristian behrenbruchTelix pharmaceuticalsCzech ministry of healthNuclear medicine instituteUniversity hospital pragueAustralian securities exchangeCzech society of nuclear medicineTreatment programmeEuropean unionCorporate communicationsTelix pharmaceuticals limited